MiLaboratories

Series A · Biotech · Bilbao, Spain · Founded 2021 · 11–50 employees

MiLaboratories is a computational biology startup that has built the gold standard platform MiXCR for analyzing next-generation sequencing data in immune system studies. Their software has processed over 10 million samples and is used by 8 out of 10 Big Pharma companies including Moderna and Bristol-Myers Squibb for vaccine development, CAR-T therapies, and antibody discovery. The company recently raised $10 million in Series A funding led by Kfund to advance their new AI-powered platform Platforma.bio, which aims to make sophisticated genomic data analysis accessible to biologists without deep bioinformatics expertise. Founded in 2021 but with technology roots dating back to 2013, the company serves both commercial clients and provides free access to academic researchers.

No open roles listed right now.